Medical Xpress news

Medical Xpress / Immune molecule long tied to inflammation may benefit the aging brain

Inflammation in the brain is usually seen as harmful in the aging process—it's thought to contribute to Alzheimer's and dementia. But a new study in mice suggests that inflammation, led by an immune molecule called STING ...

Sep 2, 2025 in Neuroscience
Medical Xpress / Fishing for a drug: Study brings hope for treating a rare disease

Despite swimming in different worlds, fish and humans are biologically much closer than one might think. Capitalizing on this kinship, researchers have now used zebrafish embryos to come up with a promising new therapy for ...

Sep 2, 2025 in Medications
Medical Xpress / A widening divide: Global health research risks drifting away from real-world disease needs, study warns

There's good news and bad news in the world of global health research. The good news is that the gap between what health scientists are studying and the actual worldwide disease burden has narrowed since 1999. That's according ...

Sep 2, 2025 in Medical research
Medical Xpress / Molecular map reveals previously hidden connections between diseases

The human body is a complex and interconnected system, where alterations caused by one disease can promote the onset of others. This tendency for certain diseases to occur together, beyond what would be expected by chance, ...

Medical Xpress / Research reveals protein ADAR1 as new therapeutic target to treat brain cancer

Research has revealed a new mechanism within cancer cells that could be exploited to treat glioblastoma—one of the deadliest types of brain tumors.

Sep 2, 2025 in Oncology & Cancer
Medical Xpress / Alzheimer's erodes brain cells' control of gene expression, undermining function and cognition

Most people recognize Alzheimer's from its devastating symptoms such as memory loss, while new drugs target pathological aspects of disease manifestations, such as plaques of amyloid proteins. Now a sweeping new study in ...

Sep 2, 2025 in Neuroscience
Medical Xpress / BlurryScope: A compact, AI-powered microscope for rapid, cost-effective cancer scoring

A research team at UCLA, led by Professor Aydogan Ozcan, has introduced BlurryScope, a compact, cost-effective scanning microscope that combines simple optical hardware with advanced deep learning algorithms to assess HER2 ...

Sep 2, 2025 in Oncology & Cancer
Medical Xpress / Weakness discovered in blood cancer cells could pave way for targeted treatment

Researchers at Karolinska Institutet have identified a vulnerability in certain blood cancer cells that makes it possible to eliminate the cancer cells with a drug, without harming healthy cells. The study is published in ...

Sep 2, 2025 in Oncology & Cancer
Medical Xpress / New method to study embryonic implantation offers hope for assisted reproduction

The use of assisted reproductive technologies like in vitro fertilization is becoming more common worldwide. However, while these technologies successfully create viable embryos, a little over half of all embryos are lost ...

Sep 2, 2025 in Obstetrics & gynaecology
Medical Xpress / Wastewater surveillance tracks spread of antibiotic resistance from mass gatherings

Mass gatherings, such as major sports events and festivals, bring together people from different regions and countries. One associated risk of such large gatherings is the potential spread of antimicrobial resistance (AMR), ...

Medical Xpress / New charts for artery stiffness could flag heart risk long before symptoms

An international team has created the first comprehensive reference measurements for blood vessel stiffness in healthy young people, a step that could give pediatric and adolescent clinics a multi-decade head start in spotting ...

Medical Xpress / Multimodal deep learning model improves risk prediction for cervical cancer radiotherapy decisions

Standard concurrent chemoradiotherapy (CCRT) for cervical cancer achieves disease-free survival (DFS) in approximately 70% of patients with locally advanced disease; however, nearly 30% still experience recurrence or metastasis.

Sep 2, 2025 in Oncology & Cancer